Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbf691a4292b963520127a6132660896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
filingDate |
2003-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd40214a3be1ddc45be8b4a65e28e76d |
publicationDate |
2004-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004017951-A1 |
titleOfInvention |
Use of bupropion for the manufacture of a medicament for treating restless legs syndrome |
abstract |
The present invention provides for use of bupropion or a pharmaceutically acceptable salt thereof in the treatment of restless legs syndrome in humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954295-B2 |
priorityDate |
2002-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |